Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate 68Ga-P3 PET/CT Imaging of PSMA Expression in Prostate

NCT05940259 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT05940259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05940259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate 68Ga-P3 PET/CT Imaging of PSMA Expression in Prostate
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
May 29, 2023
Completion date
July 31, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms